Nicholas M. Bernthal, Noah Federman, Frederick R. Eilber, Scott D. Nelson, Jeffrey J. Eckardt, Fritz C. Eilber and William D. Tap Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma Cancer 118
Version of Record online: 30 MAY 2012 | DOI: 10.1002/cncr.27651
Long-term (25-year) follow-up of patients with high-grade, localized osteosarcoma who underwent surgical resection and received chemotherapy confirms that adjuvant chemotherapy confers a statistically significant improvement in relapse-free and overall survival. Pathologic tumor necrosis >90% after a single cycle of chemotherapy is predictive of overall survival and disease-free survival in patients who go on to receive adjuvant chemotherapy.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field